abstract |
Disclosed is a use of prednisolone or prednisolone acetate and cyclosporine A in the manufacture of a medicament for the treatment of an ophthalmic disorder in a patient, wherein said prednisolone or prednisolone acetate is formulated at a concentration between 0.05% and 0.12% and said cyclosporine A is formulated at a concentration between 0.001% and 0.049% and wherein said composition is suitable for ophthalmic administration. Also described are methods, compositions, and kits for treating an immunoinflammatory disorder, an ophthalmic disorder, a musculoskeletal disorder or pain associated therewith, a periodontal disease, or a disease or condition associated with an increased serum CRP level. |